Development of complement modulating therapeutics pf age related macular degeneration
Budget:
$15,000,000 usdFunding source:
Via US Department of health & human services, national institutes of healthTimeframe:
5 yearsLead Researchers: Miss G Silvestri (UK Lead), Prof GS Hageman (PI), University of lowa, USA (Multicare study)
Similar entries
- 'Does Complement Factor h-hplotype Influence Phenotypic Expression in Familial Age Related Macular Degeneration?'
- 'Is Age-related Macular Degeneration Less Common in Light-Protected Populations'
- 'Evaluation of age-related Macualr Degeneration sub-type and Genotype with clinical response to VEGF Therapy"
- 'AD AMD Study'
- Dr Guiliana Silvestri
- Does complement factor h hplotype influence phenotypic expression in familial age related macular degeneration?
- Genetic finding implicates innate immune system in major cause of blindness
- The SERPING1 gene and age-related macular degeneration
- Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role a
- Fish oils could help prevent the leading cause of blindness in the elderly
